If you can't read this email, please view it online

Happy New Year!

Dear colleagues and friends,

The past year has been an exciting year for us at BARD, as we are marking the funds' 40th anniversary. Our board of directors took the opportunity to commence a comprehensive review process to evaluate the impact BARD has made over the past four decades. This process is almost at its end, and I am honored to say we have much to be proud of.

I would like to thank all the researchers who took part in the survey and interviews. Your feedback is very much appreciated. We all look forward to sharing the full report with you all once it is finalized.

2019 was a cornerstone year for BARD. We launched the academia-to-industry program, B-Lever in December 2018. The first round of proposals were submitted to the Israel Innovation Authority in June 2019. Today I am happy to announce the first B-Lever project focused on tomato breeding was approved and is featured below.

The week of November 18th- 24th was chosen by the world health organization to mark World Antibiotic Awareness Week. We have taken this opportunity to highlight BARD- funded research projects that face these challenges and offer possible alternatives of a non-antibiotic approach towards treating Mastitis or Staphylococci infections in dairy cattle.

Last but not least, I'd like to share my warm wishes to our retiring bookkeeper Iris Shiovits, who is leaving BARD after an impressive 35 years of dedicated work. Wishing Iris many more years of good health surrounded by family and friends. You will be missed!

Wishing you  all a very happy holiday season and a fruitful, peaceful and prosperous new year.

Prof. Yoram Kapulnik
BARD, Executive Director

Apply for 2020 Grants 

Last call to apply for our:
Postdoctoral Fellowship Program
Senior Research Fellowship Program
Graduate Student Fellowship
and The BARD International Workshop grant.

BARD at the JEDG

Prof. Yoram Kapulnik took part in the 2019 U.S.–Israel Joint Economic Development Group (JEDG). Delegations from Israel and the U.S. participated in the 34th meeting of the U.S.–Israel Joint Economic Development Group (JEDG) at the U.S. Department of State.

B-Lever Academia-to-Industry

Breeding Taste Back into Tomatoes

The ever-growing demand of consumers for improved quality of  fresh market tomatoes has led  the industry  to team-up with breeding research experts. BreedX is working together with American and Israeli researchers to produce better tasting tomatoes.

Spotlight on Research Projects

Sampling Composted Biosolids

BARD-funded study on the environmental fate of antiepileptic drugs and their metabolites: biodegradation, complexation, and photodegradation, investigating the impact of environmentally relevant biotic and abiotic processes on the fate of two common pharmaceutical compounds.

 Antibiotic Awareness

Although antimicrobials are vital to defend people, animals and plants against infections, their misuse and overuse can lead to their failure as microbes develop resistance to these life-saving treatments.
BARD-funded research projects  face these global challenges and offer a possibility for a non-antibiotic approach to treating Mastitis and Staphylococci infections in dairy cattle.

What's Happening @ BARD

Farewell, Iris!

We wish, our very own wonder woman, Iris Shiovits, all the best on her retirement from BARD, after an impressive 35 years. Iris always kept track of the big picture and used her creative side to suggest improvements for every aspect of BARD.  She has always aimed for excellences and it shows in everything she touches.

Established in 1979, BARD is a competitive funding program that supports collaborative agricultural research in areas of mutual interest to the U.S. and Israel. BARD, P.O. Box 15159 Rishon LeZion 7505101, Israel. We sent out this message to existing BARD contacts. If you no longer wish to receive these emails, simply click on the following link to unsubscribe.